Latest Ratios: P/E Ratio -0.9x · EV/EBITDA N/A · ROE N/A. (2021–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Market Cap | $26M | $28M | $69M | $564M | $743M | — |
| Enterprise Value | $28M | $30M | $69M | $564M | $743M | — |
| P/E Ratio → | -0.92 | — | — | — | — | — |
| P/S Ratio | 1922.00 | 2095.82 | — | 81180.44 | — | — |
| P/B Ratio | — | — | — | 165.19 | 6.02 | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | 2278.81 | — | 81180.33 | — | — |
| EV / EBITDA | — | — | — | — | 795.31 | — |
| EV / EBIT | — | — | — | — | 795.31 | — |
| EV / FCF | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Gross Margin | 50.2% | 50.2% | — | -7861.6% | — | — |
| Operating Margin | -96785.8% | -96785.8% | — | -76651.5% | — | — |
| Net Profit Margin | -307146.1% | -307146.1% | — | -76679.5% | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| ROE | — | — | — | -8.4% | 1.0% | -6.1% |
| ROA | -639.0% | -639.0% | -416.0% | -8.0% | 0.9% | -0.8% |
| ROIC | — | — | — | -6.3% | -1.1% | — |
| ROCE | -1090.5% | -1090.5% | — | -8.1% | -1.4% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | 0.00 | 5.32 |
| Debt / EBITDA | — | — | — | — | 0.13 | — |
| Net Debt / Equity | — | — | — | -0.00 | -0.00 | 5.32 |
| Net Debt / EBITDA | — | — | — | — | -0.45 | — |
| Debt / FCF | — | — | — | — | — | — |
| Interest Coverage | -375.28 | -375.28 | -69.66 | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.22 | 0.22 | 0.13 | 0.25 | 0.84 | — |
| Quick Ratio | 0.21 | 0.21 | 0.13 | 0.23 | 0.84 | — |
| Cash Ratio | 0.06 | 0.06 | 0.11 | 0.00 | 0.60 | — |
| Asset Turnover | — | 0.00 | — | 0.00 | — | — |
| Inventory Turnover | 0.27 | 0.27 | 14.35 | 24.32 | — | — |
| Days Sales Outstanding | — | 139.71 | — | 9969.38 | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $4M | $2M | $1M | $1M | $1M |
Imminent liquidity shortfall
As reported in financial statements, STI's price-to-sales ratio of 2468.0x reflects a market valuation detached from current revenue generation, suggesting that investors are pricing the firm as a high-risk call option on intellectual property rather than a traditional industrial entity with measurable cash flow expectations.
The extreme P/S multiple indicates that the market is assigning value almost exclusively to the potential of the underlying patent portfolio rather than operational output. This valuation appears highly sensitive to technical milestones and capital availability, rendering standard industrial valuation metrics like EV/EBITDA effectively meaningless in the current pre-commercial context.
Based on reported figures, the company's operating margin of -20.8% in 2026Q1, while improved from historical lows, remains deeply negative, confirming that the firm's earning power is currently non-existent as fixed R&D costs continue to dwarf the negligible revenue generated from sporadic material sampling.
The reported gross margin of 98.0% is likely an artifact of small-scale accounting rather than a reflection of sustainable industrial production efficiency. Investors should monitor whether the company can transition from batch-based lab synthesis to continuous manufacturing, as current margins appear to be a byproduct of R&D-stage cost structures.
According to recent SEC filings, the company's cash conversion cycle of -239,006 days in 2026Q1 highlights a complete lack of operational velocity, as the firm struggles to convert its limited R&D activities into a repeatable, high-volume transactional sales model typical of the broader electrical equipment industry.
The erratic nature of the days sales outstanding and days inventory outstanding metrics suggests that the company is not yet operating as a functional manufacturer. The extreme volatility in these efficiency ratios implies that working capital management is currently secondary to the primary challenge of achieving basic commercial viability.
As indicated by the company's reported current ratio of 0.37 in 2026Q1, the firm's liquidity position is severely strained, leaving it with minimal capacity to absorb operational shocks or fund ongoing research without immediate and significant external capital injections or parent company support.
The quick ratio of 0.36 confirms that the company lacks the liquid assets necessary to cover its short-term obligations, signaling a high risk of insolvency if the current burn rate persists. This liquidity profile warrants extreme caution, as the firm appears to be operating with virtually no margin for error.
Based on the provided data, the most commonly misapplied metric for STI is the P/E ratio, which obscures the company's true economic reality by focusing on GAAP net income that is heavily distorted by non-cash merger adjustments and stock-based compensation rather than core operational cash burn.
Analysts should prioritize 'Cash Burn from Operations' over traditional earnings metrics to accurately assess the company's runway. Relying on P/E or other profitability-based ratios in this context is misleading, as it ignores the structural reality that the firm is currently a laboratory-scale pilot plant rather than a commercial enterprise.
Includes 30+ ratios · 5 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying STI stock.
Solidion Technology Inc.'s current P/E ratio is -0.9x. This places it at the 50th percentile of its historical range.
Based on historical data, Solidion Technology Inc. is trading at a P/E of -0.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Solidion Technology Inc. has 50.2% gross margin and -96785.8% operating margin.